Non-pharmaceutical interventions for people living with HIV with cognitive impairment: A scoping review

Lucinda Stuart1, Kate Alford2, Jamie H Vera2,3

  • 1Brighton and Sussex Medical School, Brighton, United Kingdom.

Plos One
|November 25, 2024
PubMed

Insights

Computerized cognitive training may improve cognition in people with HIV, showing promise as an acceptable intervention. Further research is needed to confirm these findings and optimize treatment strategies.

Area of Science:

  • Neuroscience
  • Public Health
  • Clinical Medicine

Background:

  • Cognitive impairment (CI) affects 14% of people living with HIV, despite combination antiretroviral therapy (cART).
  • Non-pharmaceutical interventions for HIV-associated CI are not specifically recommended, despite guidelines emphasizing rehabilitation.
  • This review addresses the need for evidence on non-pharmaceutical interventions for HIV-associated CI.

Purpose of the Study:

  • To describe the types of non-pharmaceutical interventions examined in people living with HIV and CI.
  • To review the evidence supporting these interventions.

Main Methods:

  • A scoping review of studies published after January 1, 2000.
  • Inclusion criteria: English language, adult HIV population with baseline CI, no significant psychiatric or substance-misuse comorbidity.
  • Studies identified from five electronic databases.

Main Results:

  • Fourteen studies met inclusion criteria; Frascati criteria were commonly used for CI diagnosis.
  • Computerized cognitive training (CCT) was investigated in nine studies; other interventions included diet, exercise, and goal management training.
  • Eight studies showed cognitive improvement with CCT, with some lasting effects, though not always statistically significant. Patient-reported outcomes and acceptability of CCT were high.

Conclusions:

  • Heterogeneity in study design, diagnostic tools, and outcome measures complicates comparisons.
  • Computerized cognitive training (CCT) interventions show potential benefits for cognition and are well-accepted by patients.
  • Further research with larger samples is needed to identify specific components that enhance outcomes.
Abstract

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
98
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Community Based Intervention01:30

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
33
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
55